Page last updated: 2024-11-07

mk 436

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

MK 436: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID119263
SCHEMBL ID11541878
MeSH IDM0077937

Synonyms (26)

Synonym
33450-08-7
mk-436
3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitroimidazol-2-yl)-1,2-benzisoxazole
1,2-benzisoxazole, 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitroimidazol-2-yl)-
brn 0555518
mk 436
mk-0436
mk 0436
ccris 6841
3-(1-methyl-5-nitro-1h-imidazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,2-benzoxazole
3-(1-methyl-5-nitroimidazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,2-benzoxazole
SCHEMBL11541878
unii-78lfe455sz
78lfe455sz ,
SPUUHYKZDFCYGW-UHFFFAOYSA-N ,
1-methyl-2-(3a,4,5,6,7,7a-hexahydro-1,2-benz-isoxazol-3-yl)-5-nitroimidazole
mk436
j576.169g ,
1,2-benzisoxazole, 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1h-imidazol-2-yl)-
3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1h-imidazol-2-yl)-1,2-benzisoxazole
3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5nitro-1 h-imidazol-2-yl)-1,2-benzisoxazole
hexahydroisoxazole,3-(1-methyl-5-nitroimidazolyl
DTXSID00874223
3-(1-methyl-5-nitro-1h-imidazol-2-yl)-3a,4,5,6,7,7a-hexahydrobenzo[d]isoxazole
Q27266676
AKOS040753098

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" When these gels are used in combination with melarsoprol gel they are capable of curing experimental murine CNS-trypanosomiasis with a one-day treatment."( Topical chemotherapy for experimental murine African CNS-trypanosomiasis: the successful use of the arsenical, melarsoprol, combined with the 5-nitroimidazoles, fexinidazole or MK-436.
Atouguia, JM; Jennings, FW; Murray, M, 1996
)
0.29

Dosage Studied

ExcerptRelevanceReference
"Metabolite fractions from the urine of a dog dosed with 3a,4,5,6,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,2-benzisoxazole (MK-0436) were obtained by the use of high-performance liquid chromatography."( Identification of canine urinary metabolites of the antiprotozoal agent 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,2-benzisoxazole .
Arison, BH; Kirkman-Bey, N; Onofrey, D; Pile, J; Vandenheuvel, WJ; Zweig, JS, 1980
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (57.89)18.7374
1990's8 (42.11)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.36 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]